| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 2.18e-05 | 5 | 30 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.14e-03 | 138 | 30 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.51e-03 | 1180 | 30 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.65e-03 | 343 | 30 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.17e-03 | 46 | 30 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.23e-03 | 627 | 30 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | integrin binding | 2.26e-03 | 175 | 30 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | transporter activity | 2.51e-03 | 1289 | 30 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.86e-03 | 664 | 30 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.78e-03 | 61 | 30 | 2 | GO:1901682 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.70e-03 | 459 | 30 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.92e-03 | 465 | 30 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.04e-03 | 758 | 30 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 5.39e-03 | 477 | 30 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.09e-03 | 793 | 30 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 6.10e-03 | 78 | 30 | 2 | GO:0043539 | |
| GeneOntologyMolecularFunction | channel activity | 7.53e-03 | 525 | 30 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.58e-03 | 526 | 30 | 4 | GO:0022803 | |
| GeneOntologyCellularComponent | presynaptic membrane | 5.05e-05 | 277 | 31 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.39e-04 | 12 | 31 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 1.30e-03 | 36 | 31 | 2 | GO:0098992 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.55e-03 | 583 | 31 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | presynapse | 1.69e-03 | 886 | 31 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.12e-03 | 46 | 31 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | dense core granule | 3.12e-03 | 56 | 31 | 2 | GO:0031045 | |
| GeneOntologyCellularComponent | calcium channel complex | 5.24e-03 | 73 | 31 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 5.96e-03 | 78 | 31 | 2 | GO:0048787 | |
| GeneOntologyCellularComponent | T-tubule | 6.11e-03 | 79 | 31 | 2 | GO:0030315 | |
| MousePheno | abnormal artery morphology | 1.61e-06 | 440 | 28 | 8 | MP:0002191 | |
| MousePheno | mesocardia | 8.02e-06 | 20 | 28 | 3 | MP:0000650 | |
| MousePheno | abnormal aortic arch morphology | 8.73e-05 | 119 | 28 | 4 | MP:0004113 | |
| MousePheno | double outlet right ventricle, Taussig bing type | 1.38e-04 | 9 | 28 | 2 | MP:0011668 | |
| MousePheno | abnormal thoracic aorta morphology | 1.38e-04 | 134 | 28 | 4 | MP:0010468 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 1.56e-04 | 263 | 28 | 5 | MP:0011099 | |
| MousePheno | abnormal pancreatic beta cell differentiation | 1.72e-04 | 10 | 28 | 2 | MP:0009175 | |
| MousePheno | abnormal lung position or orientation | 1.96e-04 | 57 | 28 | 3 | MP:0010853 | |
| MousePheno | abnormal pulmonary artery morphology | 2.06e-04 | 58 | 28 | 3 | MP:0000484 | |
| MousePheno | double outlet right ventricle | 2.13e-04 | 150 | 28 | 4 | MP:0000284 | |
| MousePheno | right aortic arch | 2.28e-04 | 60 | 28 | 3 | MP:0004158 | |
| MousePheno | abnormal heart valve morphology | 2.93e-04 | 163 | 28 | 4 | MP:0000285 | |
| MousePheno | d-loop transposition of the great arteries | 2.98e-04 | 13 | 28 | 2 | MP:0011665 | |
| MousePheno | abnormal systemic artery morphology | 3.07e-04 | 304 | 28 | 5 | MP:0011655 | |
| MousePheno | sinus bradycardia | 3.47e-04 | 14 | 28 | 2 | MP:0010637 | |
| MousePheno | abnormal heart position or orientation | 4.24e-04 | 74 | 28 | 3 | MP:0006065 | |
| MousePheno | atrioventricular septal defect | 6.15e-04 | 84 | 28 | 3 | MP:0010412 | |
| MousePheno | abnormal endocrine pancreas development | 6.48e-04 | 19 | 28 | 2 | MP:0011932 | |
| MousePheno | abnormal atrioventricular septum morphology | 6.82e-04 | 87 | 28 | 3 | MP:0010592 | |
| MousePheno | abnormal heart and great artery attachment | 6.98e-04 | 205 | 28 | 4 | MP:0010426 | |
| MousePheno | abnormal heart and great vessel attachment | 7.37e-04 | 208 | 28 | 4 | MP:0010425 | |
| MousePheno | heterotaxia | 7.52e-04 | 90 | 28 | 3 | MP:0004133 | |
| MousePheno | abnormal aorta morphology | 9.88e-04 | 225 | 28 | 4 | MP:0000272 | |
| MousePheno | right pulmonary isomerism | 1.13e-03 | 25 | 28 | 2 | MP:0000531 | |
| MousePheno | megacephaly | 1.13e-03 | 25 | 28 | 2 | MP:0000434 | |
| Domain | G8 | 1.60e-05 | 4 | 31 | 2 | PS51484 | |
| Domain | G8 | 1.60e-05 | 4 | 31 | 2 | PF10162 | |
| Domain | G8_domain | 1.60e-05 | 4 | 31 | 2 | IPR019316 | |
| Domain | G8 | 1.60e-05 | 4 | 31 | 2 | SM01225 | |
| Domain | EGF_LAM_2 | 1.63e-05 | 30 | 31 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.63e-05 | 30 | 31 | 3 | PS01248 | |
| Domain | EGF_Lam | 2.61e-05 | 35 | 31 | 3 | SM00180 | |
| Domain | Laminin_EGF | 3.36e-05 | 38 | 31 | 3 | IPR002049 | |
| Domain | CUB | 7.24e-05 | 49 | 31 | 3 | PF00431 | |
| Domain | Pectin_lyase_fold/virulence | 7.42e-05 | 8 | 31 | 2 | IPR011050 | |
| Domain | CUB | 7.70e-05 | 50 | 31 | 3 | SM00042 | |
| Domain | - | 8.66e-05 | 52 | 31 | 3 | 2.60.120.290 | |
| Domain | CUB | 9.17e-05 | 53 | 31 | 3 | PS01180 | |
| Domain | CUB_dom | 1.14e-04 | 57 | 31 | 3 | IPR000859 | |
| Domain | Plexin_repeat | 1.28e-03 | 32 | 31 | 2 | IPR002165 | |
| Domain | PSI | 1.28e-03 | 32 | 31 | 2 | PF01437 | |
| Domain | Kringle-like | 1.28e-03 | 32 | 31 | 2 | IPR013806 | |
| Domain | Laminin_EGF | 1.53e-03 | 35 | 31 | 2 | PF00053 | |
| Domain | PSI | 2.42e-03 | 44 | 31 | 2 | IPR016201 | |
| Domain | PSI | 2.64e-03 | 46 | 31 | 2 | SM00423 | |
| Domain | - | 2.87e-03 | 48 | 31 | 2 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 3.75e-03 | 55 | 31 | 2 | IPR015915 | |
| Domain | Kelch_1 | 6.00e-03 | 70 | 31 | 2 | PF01344 | |
| Domain | Kelch_1 | 6.00e-03 | 70 | 31 | 2 | IPR006652 | |
| Domain | EGF | 6.82e-03 | 235 | 31 | 3 | SM00181 | |
| Domain | EGF-like_dom | 7.99e-03 | 249 | 31 | 3 | IPR000742 | |
| Domain | EGF_1 | 8.53e-03 | 255 | 31 | 3 | PS00022 | |
| Domain | EGF-like_CS | 9.08e-03 | 261 | 31 | 3 | IPR013032 | |
| Domain | EGF_2 | 9.47e-03 | 265 | 31 | 3 | PS01186 | |
| Domain | Ig_E-set | 1.29e-02 | 104 | 31 | 2 | IPR014756 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.17e-06 | 100 | 32 | 4 | 25807483 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 11160515 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 1309651 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 9.92e-06 | 1201 | 32 | 8 | 35696571 | |
| Pubmed | 1.79e-05 | 613 | 32 | 6 | 22268729 | ||
| Pubmed | Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. | 3.67e-05 | 10 | 32 | 2 | 15649943 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 6.44e-05 | 468 | 32 | 5 | 31056421 | |
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 20188150 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 24453333 | ||
| Pubmed | 9.76e-05 | 16 | 32 | 2 | 30579834 | ||
| Pubmed | 2.05e-04 | 23 | 32 | 2 | 26659141 | ||
| Pubmed | Cis-Repression of Foxq1 Expression Affects Foxf2-Mediated Gene Expression in Palate Development. | 2.05e-04 | 23 | 32 | 2 | 33898467 | |
| Pubmed | A genomic analysis of rat proteases and protease inhibitors. | 2.05e-04 | 23 | 32 | 2 | 15060002 | |
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 20935629 | ||
| Pubmed | 3.77e-04 | 153 | 32 | 3 | 10718198 | ||
| Pubmed | Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. | 4.25e-04 | 33 | 32 | 2 | 20203524 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 4.53e-04 | 1105 | 32 | 6 | 35748872 | |
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 5.95e-04 | 39 | 32 | 2 | 25944111 | |
| Pubmed | WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. | 6.26e-04 | 40 | 32 | 2 | 29078390 | |
| Interaction | CBLN4 interactions | 1.61e-06 | 127 | 32 | 5 | int:CBLN4 | |
| Interaction | DEFB109B interactions | 2.95e-05 | 38 | 32 | 3 | int:DEFB109B | |
| Interaction | DNASE1L1 interactions | 3.78e-05 | 120 | 32 | 4 | int:DNASE1L1 | |
| Interaction | DEFB135 interactions | 4.00e-05 | 42 | 32 | 3 | int:DEFB135 | |
| Interaction | ISLR interactions | 6.52e-05 | 138 | 32 | 4 | int:ISLR | |
| Interaction | SLURP1 interactions | 7.69e-05 | 144 | 32 | 4 | int:SLURP1 | |
| Interaction | EDDM3B interactions | 1.17e-04 | 60 | 32 | 3 | int:EDDM3B | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.51e-04 | 26 | 22 | 2 | 253 | |
| GeneFamily | Solute carriers | 1.20e-03 | 395 | 22 | 4 | 752 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.74e-07 | 179 | 32 | 5 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-07 | 180 | 32 | 5 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-07 | 180 | 32 | 5 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-07 | 187 | 32 | 5 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 2.28e-07 | 189 | 32 | 5 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 2.40e-07 | 191 | 32 | 5 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.46e-07 | 192 | 32 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-07 | 193 | 32 | 5 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-07 | 193 | 32 | 5 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 2.53e-07 | 193 | 32 | 5 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.53e-07 | 193 | 32 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.59e-07 | 194 | 32 | 5 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 2.59e-07 | 194 | 32 | 5 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-07 | 197 | 32 | 5 | 8437c33e2c4a10a1b95343431e48d5e820b1f742 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-07 | 197 | 32 | 5 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-07 | 197 | 32 | 5 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-07 | 198 | 32 | 5 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 2.94e-07 | 199 | 32 | 5 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-07 | 200 | 32 | 5 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-07 | 200 | 32 | 5 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.02e-07 | 200 | 32 | 5 | 24fa22fb93c4533a79e5d95d241a60f4b13e5631 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.02e-07 | 200 | 32 | 5 | 5109b417c066ecca0252008206b4f4b7a14c8702 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 3.02e-07 | 200 | 32 | 5 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.02e-07 | 200 | 32 | 5 | 9e5627e11288713aa9b622aae40e849dd6eacd29 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.02e-07 | 200 | 32 | 5 | 41ac6adbf61763aa8a81a0ed586c4a5542a42cc5 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.02e-07 | 200 | 32 | 5 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 7.47e-06 | 176 | 32 | 4 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | facs-Lung-EPCAM-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-06 | 177 | 32 | 4 | 2433924dcb085ebbe2545d476ebd7ee68e6092fb | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.81e-06 | 178 | 32 | 4 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 8.16e-06 | 180 | 32 | 4 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.34e-06 | 181 | 32 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 8.34e-06 | 181 | 32 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 8.71e-06 | 183 | 32 | 4 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 8.90e-06 | 184 | 32 | 4 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 9.09e-06 | 185 | 32 | 4 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 9.49e-06 | 187 | 32 | 4 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.49e-06 | 187 | 32 | 4 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 9.49e-06 | 187 | 32 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 9.69e-06 | 188 | 32 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.89e-06 | 189 | 32 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 9.89e-06 | 189 | 32 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-05 | 190 | 32 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.01e-05 | 190 | 32 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.01e-05 | 190 | 32 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 190 | 32 | 4 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.03e-05 | 191 | 32 | 4 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 193 | 32 | 4 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 1.07e-05 | 193 | 32 | 4 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 1.07e-05 | 193 | 32 | 4 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.07e-05 | 193 | 32 | 4 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.07e-05 | 193 | 32 | 4 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | Control-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 1.07e-05 | 193 | 32 | 4 | 52c0f2c7af57436f23e0c0e0c87086c47695e2c4 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 1.10e-05 | 194 | 32 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.10e-05 | 194 | 32 | 4 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.10e-05 | 194 | 32 | 4 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.10e-05 | 194 | 32 | 4 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | LAM-Endothelial|LAM / Condition, Lineage and Cell class | 1.10e-05 | 194 | 32 | 4 | 1241e3e75414b619abc9431627619f5c194ec930 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 1.10e-05 | 194 | 32 | 4 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 195 | 32 | 4 | 53b83e16b350100b1d5791a9c42bd98e37cbc0af | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 195 | 32 | 4 | 667a2ed4b865e9a37674b3d154bb5bf2188b3ebf | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 196 | 32 | 4 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 196 | 32 | 4 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.14e-05 | 196 | 32 | 4 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 196 | 32 | 4 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 196 | 32 | 4 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.14e-05 | 196 | 32 | 4 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | proximal-Endothelial-Capillary-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 197 | 32 | 4 | ddb8ea895f0f34d4f20a0740b708fa0f3e378801 | |
| ToppCell | 3'-Distal_airway-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | 9ffb823c0f3f23cc85f9fd3ca24f77817e90bd86 | |
| ToppCell | proximal-Endothelial-Capillary|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 197 | 32 | 4 | 53baef54bd85c60ae24a3c163b3a3d937fb6ff0b | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-05 | 197 | 32 | 4 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | ca6bce1a92c6326f41a6300c31da02386bafa152 | |
| ToppCell | proximal-3-Endothelial-Capillary|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-05 | 197 | 32 | 4 | a1a61c03d67272693ec23e0d15f0a12bf618e2da | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-05 | 197 | 32 | 4 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 197 | 32 | 4 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 197 | 32 | 4 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 32 | 4 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-05 | 198 | 32 | 4 | 307dd09e6bc820a148f3000f18dae7aedba4be0b | |
| ToppCell | distal-1-Endothelial-Lymphatic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.19e-05 | 198 | 32 | 4 | b6fea363463c8dd7e6780c085ece4900266a6286 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 5eedcc20e35adbabe268a93b748ee4566b3ffb66 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 3aae7d146ebbb34da3239041a7c0334abff2597f | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.19e-05 | 198 | 32 | 4 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-05 | 198 | 32 | 4 | 447d7182edb2cd8a72ebd3c0d16bc6e4ddcaaa5c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-05 | 198 | 32 | 4 | 40c2171e79f578c9116d872c189f953dc61d052d | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-05 | 198 | 32 | 4 | 122215d9288533ad03562cf777e846504863df9a | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-05 | 199 | 32 | 4 | 3fea92affacd4c1f588fa81807df35d6c69b7241 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 199 | 32 | 4 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 199 | 32 | 4 | 920299626a9ec8e50d944f5a7667e855de7edd72 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.21e-05 | 199 | 32 | 4 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 993999adf346b4fd557989bc53c17eb0ccb996c9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 199 | 32 | 4 | ddfb725ccbcadbd188e20b60a7567e1f8245f18d | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.21e-05 | 199 | 32 | 4 | 523e01f6a0abd9820697572e042a381aae8932dc | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 32 | 4 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 32 | 4 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.21e-05 | 199 | 32 | 4 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 0d0d5cb821db16514192ad536849a8a04e22e637 | |
| Drug | 2-aminomethyl-2-tricyclo(3.3.1.1(1,7))decaneacetic acid hydrochloride | 5.74e-06 | 3 | 32 | 2 | ctd:C503772 | |
| Drug | methyl beta-aminocrotonate | 1.91e-05 | 5 | 32 | 2 | CID000084253 | |
| Drug | Nilvadipine | 1.91e-05 | 5 | 32 | 2 | DB06712 | |
| Drug | Nisoldipine | 1.91e-05 | 5 | 32 | 2 | DB00401 | |
| Drug | nemadipine-A | 1.91e-05 | 5 | 32 | 2 | CID002856102 | |
| Drug | B 874-67 | 1.91e-05 | 5 | 32 | 2 | CID000195466 | |
| Drug | CPU-23 | 2.86e-05 | 6 | 32 | 2 | CID003036051 | |
| Drug | Amlodipine | 4.00e-05 | 7 | 32 | 2 | DB00381 | |
| Drug | Isradipine | 4.00e-05 | 7 | 32 | 2 | DB00270 | |
| Drug | Nitrendipine | 5.33e-05 | 8 | 32 | 2 | DB01054 | |
| Drug | Nifedipine | 5.33e-05 | 8 | 32 | 2 | DB01115 | |
| Drug | methcathinone | 8.55e-05 | 10 | 32 | 2 | CID000001576 | |
| Drug | Felodipine | 1.04e-04 | 11 | 32 | 2 | DB01023 | |
| Disease | Sinus Node Dysfunction (disorder) | 1.04e-04 | 15 | 30 | 2 | C0428908 | |
| Disease | progression free survival, ovarian serous carcinoma | 2.28e-04 | 22 | 30 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | dyslexia | 5.91e-04 | 162 | 30 | 3 | EFO_0005424 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 6.51e-04 | 37 | 30 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | hepatocyte growth factor measurement | 9.21e-04 | 44 | 30 | 2 | EFO_0006903 | |
| Disease | waist-hip ratio | 1.28e-03 | 1226 | 30 | 6 | EFO_0004343 | |
| Disease | fish consumption measurement | 1.94e-03 | 64 | 30 | 2 | EFO_0010139 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQYFLSSSLFFFNEN | 3806 | Q86UQ4 | |
| SFQRNNDALDAALFY | 1656 | Q8TDJ6 | |
| TFGYLFFFSNASLLN | 771 | Q5U651 | |
| RAGYALTLFAFNNRF | 1146 | Q7Z5J8 | |
| YFLGFLSNSKRFNVA | 1121 | Q9BXT6 | |
| ANYNLLGFNASFRFS | 126 | Q7Z7M0 | |
| FTGLSIAYFNFGNQL | 76 | Q6P1A2 | |
| LYFFSDRINQAQGFA | 301 | Q96MU8 | |
| NSNFAQRFQGIYRCF | 101 | P32004 | |
| RNAAASLSLFYNNGA | 1421 | O15230 | |
| AFFLLSNGYQRQLSF | 991 | Q6IE36 | |
| SQAHYRLSAFGQQFL | 96 | Q9P2N4 | |
| GFSFAFEQLLNYNVS | 336 | P54289 | |
| FFSDAAYNLTGFNIF | 191 | Q5VV63 | |
| FYNNRVHSNFKAGLF | 716 | Q9UHN6 | |
| AFLKAQAAFFGSYRN | 311 | Q8TEH3 | |
| GFATAFDFLYNLLDN | 176 | Q8IZU8 | |
| SLGLQAYFVSLFNRF | 576 | Q01668 | |
| QFLQSRFPFFRGSYQ | 76 | Q12946 | |
| LGSYADAFQFLAQFL | 251 | Q5HYW3 | |
| NSLYNAASLFGFPFQ | 61 | Q9HC62 | |
| NSFFLALYAFFNLSL | 451 | Q8NBS3 | |
| FRSENNCFLYGVFNG | 56 | Q15750 | |
| RAFDYFNLAANAGNS | 396 | Q9UBV2 | |
| SFSYFNGFNSLLNNM | 216 | Q9UJS0 | |
| AYSNAVANLFRQLGF | 111 | Q6PCB7 | |
| FNVLSYRSLGNCSFF | 226 | Q495A1 | |
| TNGFQATARDAFSYN | 1221 | Q86WI1 | |
| GQAFNLTLYFRNRSF | 36 | O43548 | |
| AQQTFFAALGAYNFC | 986 | Q14997 | |
| FGVLLAFASYNKFNN | 341 | P31645 | |
| YAAASQSCNFALRFF | 556 | Q14CX7 |